Peijia Medical Ltd. ( (HK:9996) ) just unveiled an announcement.
Peijia Medical Limited announced that its YonFlow® Flow Diverting Stent has received approval from the National Medical Products Administration of the PRC for its registration application. This stent, developed by Jiangsu NowYon Medical Limited, is notable for being the first globally retrievable flow diverting stent, offering enhanced control during medical procedures. The approval marks a significant step in Peijia Medical’s strategy to expand its product offerings and strengthen its position in the Greater China market, although there is no guarantee of successful commercialization.
More about Peijia Medical Ltd.
Peijia Medical Limited, incorporated in the Cayman Islands, operates in the medical device industry, focusing on innovative products for the treatment of structural heart and neurovascular diseases. The company aims to enhance its market presence in Greater China through strategic partnerships and product development.
YTD Price Performance: 4.17%
Technical Sentiment Signal: Buy
Current Market Cap: €349.3M
For detailed information about 9996 stock, go to TipRanks’ Stock Analysis page.